Abstract:The results of human observational studies on the correlation between gut microbiota perturbations and polycystic ovary syndrome (PCOS) have been contradictory. This study aimed to perform the first systematic review and meta-analysis to evaluate the specificity of the gut microbiota in PCOS patients compared to healthy women.Literature through May 22, 2023, was searched on PubMed, Web of Science, Medline, Embase, Cochrane Library, and Wiley Online Library databases. Unreported data in diversity indices were filled by downloading and processing raw sequencing data. Systematic review inclusion: original studies were eligible if they applied an observational case-control design, performed gut microbiota analysis and reported diversity or abundance measures, sampled general pre-menopausal women with PCOS, and are longitudinal studies with baseline comparison between PCOS patients and healthy females. Systematic review exclusion: studies that conducted interventional or longitudinal comparisons in the absence of a control group. Two researchers made abstract, full-text, and data extraction decisions, independently. The Joanna Briggs Institute Critical Appraisal Checklist was used to assess the methodologic quality. Hedge's g standardized mean difference (SMD), confidence intervals (CIs), and heterogeneity (I2) for alpha diversity were calculated. Qualitative syntheses of beta-diversity and microbe alterations were performed.Twenty-eight studies (n = 1022 patients, n = 928 control) that investigated gut microbiota by collecting stool samples were included, with 26 and 27 studies having provided alpha-diversity and beta-diversity results respectively. A significant decrease in microbial evenness and phylogenetic diversity was observed in PCOS patients when compared with control participants (Shannon index: SMD = - 0.27; 95% CI, - 0.37 to - 0.16; phylogenetic diversity: SMD = - 0.39; 95% CI, -- 0.74 to - 0.03). We also found that reported beta-diversity was inconsistent between studies. Despite heterogeneity in bacterial relative abundance, we observed depletion of Lachnospira and Prevotella and enrichment of Bacteroides, Parabacteroides, Lactobacillus, Fusobacterium, and Escherichia/Shigella in PCOS. Gut dysbiosis in PCOS, which might be characterized by the reduction of short-chain fatty acid (SCFA)-producing and bile-acid-metabolizing bacteria, suggests a shift in balance to favor pro-inflammatory rather than anti-inflammatory bacteria.Gut dysbiosis in PCOS is associated with decreased diversity and alterations in bacteria involved in microbiota-host crosstalk.PROSPERO registration: CRD42021285206, May 22, 2023.

Gut microbiota alterations reveal potential gut–brain axis changes in polycystic ovary syndrome

Microbiota Alters and Its Correlation with Molecular Regulation Underlying Depression in PCOS Patients

Dysbiosis of Gut Microbiota Associated with Clinical Parameters in Polycystic Ovary Syndrome

Unveiling the complex interplay between gut microbiota and polycystic ovary syndrome: A narrative review

Dysbiotic alteration in the fecal microbiota of patients with polycystic ovary syndrome

Gut microbiome in PCOS associates to serum metabolomics: a cross-sectional study

Alterations of Gut Microbiome and Fecal Fatty Acids in Patients With Polycystic Ovary Syndrome in Central China

Gut Microbiota As a Potential Target for Treatment of Polycystic Ovary Syndrome

Metagenomic Analysis Identified Microbiome Alterations and Pathological Association Between Intestinal Microbiota and Polycystic Ovary Syndrome

Gut microbiota–bile acid–interleukin-22 axis orchestrates polycystic ovary syndrome

Perturbations in Gut Microbiota Composition in Patients with Polycystic Ovary Syndrome: a Systematic Review and Meta-Analysis

Gut Microbiota in Patients with Polycystic Ovary Syndrome: a Systematic Review

Gut Microbiome Composition in Polycystic Ovary Syndrome Adult Women: A Systematic Review and Meta-analysis of Observational Studies

Role of the gut microbiota and innate immunity in polycystic ovary syndrome: Current updates and future prospects

Gut microbiota in women with polycystic ovary syndrome: an individual based analysis of publicly available data

Alterations in the intestinal microbiome associated with PCOS affect the clinical phenotype

Gut Microbiota and the Polycystic Ovary Syndrome: Influence of Sex, Sex Hormones, and Obesity

Alterations of Gut Microbiota Biodiversity and Relative Abundance in Women with PCOS: A Systematic Review and Meta-Analysis

The gut microbial composition in polycystic ovary syndrome with hyperandrogenemia and its association with steroid hormones

Association between Polycystic Ovary Syndrome and Gut Microbiota

Unraveling intestinal microbiota's dominance in polycystic ovary syndrome pathogenesis over vaginal microbiota